UAL:NASDAQUnited Airlines Holdings, Inc. Analysis
Data as of 2026-05-28 - not real-time
$112.62
Latest Price
8/10Risk
Risk Level: High
Executive Summary
United Airlines is trading at $112.62, well above its DCF‑derived fair value of $52.48, suggesting the market is pricing in strong near‑term momentum. Revenue growth of 10.6% and a PE ratio of 10.1 – far below the industry average of 30.1 – highlight relative valuation attractiveness, yet the stock’s RSI of 70.3 and proximity to the $114.35 resistance level signal short‑term overbought conditions. Technicals remain bullish with a MACD histogram of +1.66 and the 20‑day SMA (96.45) comfortably beneath the current price, while the 30‑day volatility of 57.7% and a computed beta of 2.46 underscore heightened price swings. Recent news points to a resurgence in premium travel demand, the launch of new long‑haul routes to Japan, and benefits from cheaper jet fuel following the Spirit Airlines shutdown, all of which could sustain earnings momentum. However, the company carries a substantial debt load (Debt/Equity > 195) and a max drawdown of –27.5%, raising concerns about financial resilience in a volatile sector. The market’s “Extreme Greed” sentiment (Fear‑Greed Index 92.34) further amplifies the risk of a correction. In sum, while fundamentals and growth catalysts are compelling, the current price premium and elevated risk metrics warrant a cautious stance.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- RSI indicating overbought conditions
- Price near resistance at $114.35
- High short‑term volatility
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Revenue growth of 10.6% and expanding premium demand
- Bullish MACD and price above key moving averages
- Undervalued relative to industry PE multiples
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Strategic route expansion into high‑yield Asian markets
- Improving operating margins and solid cash flow generation
- Long‑term upside potential of ~15% above current price
Key Metrics & Analysis
Financial Health
Revenue Growth10.60%
Profit Margin6.06%
P/E Ratio10.1
ROE25.73%
ROA4.14%
Debt/Equity195.08
P/B Ratio2.3
Op. Cash Flow$9.5B
Free Cash Flow$1.6B
Industry P/E30.1
Technical Analysis
TrendNeutral
RSI70.3
Support$87.95
Resistance$114.35
MA 20$96.45
MA 50$94.67
MA 200$101.43
MACDBullish
VolumeStable
Fear & Greed Index92.34
Valuation
Fair Value$52.49
Target Price$130.42
Upside/Downside15.80%
GradeOvervalued
TypeBlend
Risk Assessment
Beta2.46
Volatility57.67%
Sector RiskHigh
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.